Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial |
Reference |
Staphylococcus aureus (HT2001254 + methicillin-resistant) |
- |
- |
32 - ? |
RRP9W4N |
1361 |
Staphylococcus aureus (human) |
- |
- |
2000 - ? |
Cymbopogon proximus (Essential oil) |
855 |
Staphylococcus aureus (I-11574) |
- |
- |
2 - ? |
Amphipathic-2D (Peptide) |
296 |
Staphylococcus aureus (I-11574) |
- |
- |
3 - ? |
Amphipathic-3D (Peptide) |
296 |
Staphylococcus aureus (I-11574) |
- |
- |
4 - ? |
Amphipathic-1D (Peptide) |
296 |
Staphylococcus aureus (I-11574) |
- |
- |
4 - ? |
Scrambled-4D (Peptide) |
296 |
Staphylococcus aureus (I-11574) |
- |
- |
>4 - ? |
Segregated-5D (Peptide) |
296 |
Staphylococcus aureus (I-11574) |
- |
- |
>4 - ? |
Segregated-6D (Peptide) |
296 |
Staphylococcus aureus (IAM 1011) |
- |
- |
12800 - ? |
Catechin |
1212 |
Staphylococcus aureus (IFO 12732) |
- |
- |
0 - 0.78 |
(3E)-hexenal |
842 |
Staphylococcus aureus (IFO 12732) |
- |
- |
0 - 1.56 |
(2E)-hexenal |
842 |
Staphylococcus aureus (IFO 12732) |
- |
- |
0 - 6.25 |
(3E)-hexenol |
842 |
Staphylococcus aureus (IFO 12732) |
- |
- |
0 - 6.25 |
n-hexanal |
842 |
Staphylococcus aureus (IFO 12732) |
- |
- |
0 - 6.25 |
n-hexanol |
842 |
Staphylococcus aureus (IHMA127277 + USA) |
- |
- |
2 - ? |
Retapamulin |
601 |
Staphylococcus aureus (inducible + erm(A)) |
0.03 |
0.06 |
0.004 - 0.25 |
Cethromycin (ABT-773) |
954 |
Staphylococcus aureus (inducible + erm(A)) |
>128 |
>128 |
1 - >128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
954 |
Staphylococcus aureus (inducible erm(A)) |
0.03 |
0.25 |
0.03 - 0.25 |
Cethromycin (ABT-773) |
15 |
Staphylococcus aureus (inducible erm(A)) |
128 |
0.06 |
0.06 - 0.12 |
Clindamycin (Cleocin) |
15 |
Staphylococcus aureus (inducible erm(A)) |
>128 |
>128 |
2 - >128 |
Clarithromycin (Biaxin) |
15 |
Staphylococcus aureus (inducible erm(A)) |
>128 |
>128 |
4 - >128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
15 |
Staphylococcus aureus (inducible erm(A)) |
>128 |
>128 |
8 - >128 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
15 |
Staphylococcus aureus (innsbruck + methicillin-resistant) |
- |
- |
>64 - ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
187 |
Staphylococcus aureus (IS-58 + methicillin-resistant tet(K)) |
- |
- |
32 - ? |
Tetracycline + 10μg/ml reserpine |
69 |
Staphylococcus aureus (IS-58 + methicillin-resistant tet(K)) |
- |
- |
128 - ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
69 |
Staphylococcus aureus (ISP 794) |
- |
- |
0.032 - ? |
Moxifloxacin (BAY 12-8039, Avelox) |
365 |
Staphylococcus aureus (ISP 794) |
- |
- |
0.125 - 0.25 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
365 |
Staphylococcus aureus (ISP 794) |
- |
- |
0.125 - ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1034 |